U.S. Physical Therapy (USPH)
(Delayed Data from NYSE)
$84.75 USD
+0.30 (0.36%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $84.72 -0.03 (-0.04%) 6:16 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$84.75 USD
+0.30 (0.36%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $84.72 -0.03 (-0.04%) 6:16 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Zacks News
U.S. Physical Therapy (USPH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ADUS or USPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ADUS vs. USPH: Which Stock Is the Better Value Option?
Top Ranked Momentum Stocks to Buy for April 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 25th
ADUS vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADUS vs. USPH: Which Stock Is the Better Value Option?
ARA vs. USPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ARA vs. USPH: Which Stock Is the Better Value Option?
ARA vs. USPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ARA vs. USPH: Which Stock Is the Better Value Option?
LHCG vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
LHCG vs. USPH: Which Stock Is the Better Value Option?
EHC vs. USPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EHC vs. USPH: Which Stock Is the Better Value Option?
U.S. Physical Therapy (USPH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 12.28% and 0.75%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
U.S. Physical Therapy (USPH) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
U.S. Physical Therapy (USPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EVHC vs. USPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EVHC vs. USPH: Which Stock Is the Better Value Option?
EVHC vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
EVHC vs. USPH: Which Stock Is the Better Value Option?
U.S. Physical Therapy (USPH) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of 4.29% and 1.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
EHC vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
EHC vs. USPH: Which Stock Is the Better Value Option?
DVA vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
DVA vs. USPH: Which Stock Is the Better Value Option?
ADUS vs. USPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADUS vs. USPH: Which Stock Is the Better Value Option?